Transcript Document

BioSciencs Foro
Joaquin Guinea
Chairman of BIOMADRID
(www.biomadrid.org)
November 8th, New York
GLOBAL DATA ON THE REGION
OF MADRID R&D
•
288,800 people employed in the high technology sectors
(10.7% of the working population).
•
Investment in R&D: 2,400 million euros (1.76% of the GDP).
•
40,000 workers in R&D.
•
15 universities and more than 50 academic research centres.
•
230,000 university students and 2,000 doctorate students
every year.
•
27.3% of Spanish scientists are in Madrid and they produce
31% of the scientific publications in Spain.
•
More than 20 technology transfer centres.
•
Three fully operating scientific parks and another three under
construction.
MADRID BIOSCIENCE REGION IN
FIGURES
•
37 companies fully dedicated to biotechnology are located in
Madrid (32% of the total spanish companies). 83% of the
investment in R&D by biotechnology companies in Spain takes
place in Madrid.
•
400 biomedical companies (with around 25,000 workers) are
located in Madrid.
•
5,000 Life Sciences researchers work in academic centres in
Madrid.
•
31% of the Spanish biomedical scientific publications have its
origin in Madrid.
•
More than 300 new PhD graduates in Life Sciences every year.
•
More than 25,000 patients involved in more than 1,000 clinical
trials every year, in 75 hospital centres.
SOME EXAMPLES OF MADRID
BIOTECH COMPANIES
R&D PROJECTS
•
Cell Therapy based on the use of stem cells obtained from
adults.
•
Generation of new therapeutic molecules based on antibodies
for treatment of degenerative and inflammatory infectious
diseases.
•
Development of genetic engineering tools for medical diagnosis,
the agro-food industry and environmental control (clinical and
molecular diagnosis).
•
Development of precision analytical equipment by means of
biosensors (nanobiotechnology).
•
New systems to produce recombinant proteins in genetically
modified plants (with application in chemical&food industry) or
from insect larvae (with application in animal health).
•
Diagnosis and treatment of allergies by development of an
individualized molecular immunotherapy.
BIOTECH SECTOR SUPPORT
FROM PUBLIC SECTOR
• EUROPEAN COMMISION
• SPANISH GOVERNMENT
Ministery of Education
Ministery of Industry
• MADRID REGIONAL GOVERNMENT
Directorate General of Technological Innovation
Madrid Development Agency (IMADE)
PROMOMADRID
• MADRID CITY COUNCIL